238 related articles for article (PubMed ID: 34752487)
1. Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells.
Tyumentseva MA; Tyumentsev AI; Akimkin VG
PLoS One; 2021; 16(11):e0259812. PubMed ID: 34752487
[TBL] [Abstract][Full Text] [Related]
2. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
[TBL] [Abstract][Full Text] [Related]
3. Packaging and Uncoating of CRISPR/Cas Ribonucleoproteins for Efficient Gene Editing with Viral and Non-Viral Extracellular Nanoparticles.
Mazurov D; Ramadan L; Kruglova N
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992399
[TBL] [Abstract][Full Text] [Related]
4. Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing.
Dubey S; Chen Z; Jiang YJ; Talis A; Molotkov A; Ali A; Mintz A; Momen-Heravi F
Theranostics; 2024; 14(7):2777-2793. PubMed ID: 38773978
[TBL] [Abstract][Full Text] [Related]
5. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
Wilbie D; Walther J; Mastrobattista E
Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553
[TBL] [Abstract][Full Text] [Related]
6. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
Chen S; Lee B; Lee AY; Modzelewski AJ; He L
J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
[TBL] [Abstract][Full Text] [Related]
7. Genome editing via delivery of Cas9 ribonucleoprotein.
DeWitt MA; Corn JE; Carroll D
Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976
[TBL] [Abstract][Full Text] [Related]
8. Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells.
Liu W; Rudis MR; Cheplick MH; Millwood RJ; Yang JP; Ondzighi-Assoume CA; Montgomery GA; Burris KP; Mazarei M; Chesnut JD; Stewart CN
Plant Cell Rep; 2020 Feb; 39(2):245-257. PubMed ID: 31728703
[TBL] [Abstract][Full Text] [Related]
9. Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor.
Kim YS; Kim GR; Park M; Yang SC; Park SH; Won JE; Lee JH; Shin HE; Song H; Kim HR
Tissue Eng Regen Med; 2020 Feb; 17(1):45-53. PubMed ID: 32002841
[TBL] [Abstract][Full Text] [Related]
10. DNA-Free Genome Editing via Ribonucleoprotein (RNP) Delivery of CRISPR/Cas in Lettuce.
Park J; Choi S; Park S; Yoon J; Park AY; Choe S
Methods Mol Biol; 2019; 1917():337-354. PubMed ID: 30610648
[TBL] [Abstract][Full Text] [Related]
11. Delivery of CRISPR-Cas12a Ribonucleoprotein Complex for Genome Editing in an Embryogenic Citrus Cell Line.
Fang H; Culver JN; Niedz RP; Qi Y
Methods Mol Biol; 2023; 2653():153-171. PubMed ID: 36995625
[TBL] [Abstract][Full Text] [Related]
12. Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
Xu H; Kita Y; Bang U; Gee P; Hotta A
STAR Protoc; 2021 Dec; 2(4):100965. PubMed ID: 34825222
[TBL] [Abstract][Full Text] [Related]
13. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.
Bykonya AG; Lavrov AV; Smirnikhina SA
Mol Biotechnol; 2023 Feb; 65(2):181-195. PubMed ID: 35322386
[TBL] [Abstract][Full Text] [Related]
14. [Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].
Li X; Shi W; Geng LZ; Xu JP
Yi Chuan; 2020 Jun; 42(6):556-564. PubMed ID: 32694114
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9 mediated high efficiency knockout of the eye color gene Vermillion in Helicoverpa zea (Boddie).
Perera OP; Little NS; Pierce CA
PLoS One; 2018; 13(5):e0197567. PubMed ID: 29771955
[TBL] [Abstract][Full Text] [Related]
16. PEG-Delivered CRISPR-Cas9 Ribonucleoproteins System for Gene-Editing Screening of Maize Protoplasts.
Sant'Ana RRA; Caprestano CA; Nodari RO; Agapito-Tenfen SZ
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32887261
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
Bloomer H; Khirallah J; Li Y; Xu Q
Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274
[TBL] [Abstract][Full Text] [Related]
18. Targeted Genome Editing Using DNA-Free RNA-Guided Cas9 Ribonucleoprotein for CHO Cell Engineering.
Shin J; Lee N; Cho S; Cho BK
Methods Mol Biol; 2018; 1772():151-169. PubMed ID: 29754227
[TBL] [Abstract][Full Text] [Related]
19. Introducing a Spectrum of Long-Range Genomic Deletions in Human Embryonic Stem Cells Using Type I CRISPR-Cas.
Dolan AE; Hou Z; Xiao Y; Gramelspacher MJ; Heo J; Howden SE; Freddolino PL; Ke A; Zhang Y
Mol Cell; 2019 Jun; 74(5):936-950.e5. PubMed ID: 30975459
[TBL] [Abstract][Full Text] [Related]
20. Chemical Modification of Guide RNAs for Improved CRISPR Activity in CD34+ Human Hematopoietic Stem and Progenitor Cells.
Shapiro J; Tovin A; Iancu O; Allen D; Hendel A
Methods Mol Biol; 2021; 2162():37-48. PubMed ID: 32926376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
